rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Keysight Technologies Inc.

KEYS · NYSE

Health CareLife-science toolsJust dropped outDefense-Tech

KEYS stood above a rising 150-day average in 51 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 0.8% below that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Just dropped out
Weeks in an uptrend
out for 1
Industry in uptrend
52% +4 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$50.5M
Officials’ trades on record
24

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 51 of 52 weeks.

17 Apr – 16 Oct
26%41%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$21.2M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

24 disclosed lines: House 11, Senate 9, executive 4; 12 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$100k–$250k9 Apr 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k23 Mar 2026filed 14 May 2026
Stephen I. Miran Executive branch: Office of Government EthicsCouncil of Economic Adviserssold$15k–$50k9 Jun 2025filed 6 Sep 2025
Lori Chavez-DeRemer Executive branch: Office of Government EthicsDepartment of Laborsold$1k–$15k28 Apr 2025filed 9 Sep 2025
Jefferson Shreve House: U.S. House ClerkIN06sold$15k–$50k11 Apr 2025filed 8 May 2025
Robert P. Bresnahan, Jr. House: U.S. House ClerkPA08bought$1k–$15k8 Apr 2025filed 8 May 2025
Tommy Tuberville Senate: U.S. Senate eFDSenatorsoldjoint$1k–$15k4 Apr 2024filed 15 May 2024
Thomas R. Carper Senate: U.S. Senate eFDSenatorsoldspouse$1k–$15k22 May 2023filed 30 Jun 2023
Susie Lee House: U.S. House ClerkNV03soldjoint$1k–$15k9 May 2023filed 26 May 2023
Cynthia Axne House: U.S. House ClerkIA03bought$1k–$15k13 Jan 2022filed 8 Feb 2022
Tommy Tuberville Senate: U.S. Senate eFDSenatorboughtjoint$1k–$15k30 Sep 2021filed 15 Oct 2021
Cynthia Axne House: U.S. House ClerkIA03bought$1k–$15k11 Jun 2021filed 8 Oct 2021

Insiders

Buy orders, 12 months0
Sale orders, 12 months27
Buyers · sellers0 · 13
WhoDidSharesTraded
Satish DhanasekaranPresident and CEOsold3,000at $364.1330 Sep 2026filed 2 Oct 2026
Lisa M. PooleVP and Controllersold200at $348.0123 Sep 2026filed 25 Sep 2026
Neil DoughertyEVP and CFOsold2,000at $340.7921 Sep 2026filed 23 Sep 2026
Ingrid A. EstradaSVPsold2,000at $326.104 Sep 2026filed 9 Sep 2026
Jean McClung NyeDirectorsold3,000at $319.2221 Aug 2026filed 25 Aug 2026
Ingrid A. EstradaSVPsold2,000at $314.6620 Aug 2026filed 24 Aug 2026
Ingrid A. EstradaSVPsold2,000at $340.8730 Jun 2026filed 2 Jul 2026
Satish DhanasekaranPresident and CEOsold507at $361.3225 Jun 2026filed 29 Jun 2026
James CullenDirectorsold3,000at $346.582 Jun 2026filed 4 Jun 2026
Richard P. HamadaDirectorsold870at $275.7830 Mar 2026filed 1 Apr 2026
Neil DoughertyEVP and CFOsold2,000at $298.3724 Mar 2026filed 26 Mar 2026
Satish DhanasekaranPresident and CEOsold1,667at $300.0024 Mar 2026filed 26 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

Everyone who traded it

Satish Dhanasekaran Company insiderPresident and CEO · last 30 Sep 20260 · 22
Lisa M. Poole Company insiderVP and Controller · last 23 Sep 20260 · 4
Neil Dougherty Company insiderEVP and CFO · last 21 Sep 20260 · 15
Ingrid A. Estrada Company insiderSVP · last 4 Sep 20260 · 19
Scott Reese Company insiderDirector · last 26 Aug 20260 · 0
Jean McClung Nye Company insiderDirector · last 21 Aug 20262 · 1
Arnaud Allouche Company insiderSVP · last 6 Jul 20260 · 0
James Cullen Company insiderDirector · last 2 Jun 20260 · 4
Jo Ann Juskie Company insiderSVP · last 26 May 20260 · 1
Donald J. Trump Executive branchWhite House Office · last 9 Apr 20261 · 1
Richard P. Hamada Company insiderDirector · last 30 Mar 20260 · 7
Jeffrey K. Li Company insiderSVP and Secretary · last 24 Mar 20260 · 8

Same industry

OABI OmniAbLeading+65%
TXG 10x GenomicsLeading+60%
AVTR AvantorLeading+47%
ILMN IlluminaLeading+44%
RVTY RevvityLeading+37%
MASS 908 DevicesLeading+31%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Oct 202562.1%
Operating profit marginFY 2025 · to 31 Oct 202516.3%
Free cash flow marginFY 2025 · to 31 Oct 202523.8%
Return on capital employedFY 2025 · to 31 Oct 20259.3%
Cash conversionFY 2025 · to 31 Oct 2025166%
Debt to equityFY 2025 · to 31 Oct 20250.43×
Interest coverFY 2025 · to 31 Oct 20259.13×
Research spendFY 2025 · to 31 Oct 202518.7%
Share count trendFY 2025 · to 12 Dec 2025-0.7%
Cash and equivalentsFY 2025 · to 31 Oct 2025$1.9B
Free cash flowFY 2025 · to 31 Oct 2025$1.3B

Analyst forecasts

No analyst forecasts yet.